LL-37 KR-12-a5

General Information


DRACP ID  DRACP03539

Peptide Name   LL-37 KR-12-a5

Sequence  KRIVKLILKWLR

Sequence Length  12

UniProt ID  P49913 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03539

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C76H136N22O13

Absent amino acids  ACDEFGHMNPQSTY

Common amino acids  KL

Mass  176245

Pl  12.55

Basic residues  5

Acidic residues  0

Hydrophobic residues  7

Net charge  5

Boman Index  -1552

Hydrophobicity  25

Aliphatic Index  186.67

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  500

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 28525841

Title  LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity

Doi Not available

Year  2017

Literature 2

Pubmed ID 29022391

Title  KR-12-a5 is a non-cytotoxic agent with potent antimicrobial effects against oral pathogens

Doi Not available

Year  2017

Literature 3

Pubmed ID 24105706

Title  Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity

Doi Not available

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  6830

DRACP is developed by Dr.Zheng's team.